No Data
Progress report on the establishment of the Kao Mirai Coexistence Foundation one year after its founding.
Reference material: News of individual stocks released on February 28, 2025, progress report of the Kao Mirai Coexistence Foundation established one year ago ~ aiming to improve the QOL of consumers ~ The general incorporated foundation Kao Mirai Coexistence Foundation (Chairperson: Yumi Takeuchi) has been active since its establishment in September 2023, supporting each individual consumer through various activities that lead to a clean, beautiful, healthy, and considerate lifestyle, aiming for a rich lifestyle for all people and a secure and harmonious future.
Kao Corporation won the "Human Resource Utilization Award" at the "Nikkei Smart Work Grand Prize 2025."
Reference Materials: On February 28, 2025, a news release regarding management and financial sustainability announced that Kao Corporation received the "Human Resource Utilization Award" at the "Nikkei Smart Work Awards 2025." Kao Corporation (President Yoshihiro Hasebe) has recently been awarded the "Human Resource Utilization Award" at the "Nikkei Smart Work Awards 2025," organized by the Nihon Keizai Shimbun. The Nikkei Smart Work Awards recognize companies that enhance productivity and achieve sustainable growth through work style reforms.
Kao Corporation was awarded the highest honor, the Cabinet Office Minister's Award, at the '2024 Consumer-Oriented Management Excellent Case Award'.
Reference materials: News release on February 28, 2025, Management and Financial Sustainability Product and Brand Awards. Kao Corporation has received the highest award, the Cabinet Office Special Minister Award, at the '2024 Consumer-Oriented Management Excellent Case Awards' hosted by the Consumer Affairs Agency. Kao Corporation (President Yoshihiro Hasebe) has recently been awarded the highest Cabinet Office Special Minister Award at the '2024 Consumer-Oriented Management Excellent Case Awards' hosted by the Consumer Affairs Agency. The Consumer-Oriented Management Excellent Case Awards recognize outstanding examples of management that co-create and collaborate with consumers.
The physician-led phase 1 trial of Nano mRNA---3Q TUG1 ASO (glioblastoma) is proceeding smoothly.
On the 14th, NANO MRNA (4571) announced its consolidated financial results for the third quarter of the fiscal year ending March 2025 (April-December 2024). Revenue was 0.083 billion yen, a 20.3% decrease compared to the same period last year, operating loss was 0.485 billion yen (compared to a loss of 0.687 billion yen in the same period last year), recurring loss was 0.446 billion yen (compared to a loss of 0.663 billion yen in the same period last year), and net loss attributable to shareholders of the parent company was 0.595 billion yen (compared to a loss of 0.737 billion yen in the same period last year). Regarding the main research and development progress during the cumulative period of the third quarter, TUG1
List of convertible stocks (Part 1) [List of Parabolic Signal convertible stocks]
○ List of stocks that have shifted to Buy Market Code Stock Name Closing Price SAR Main Board <2060> Feed One 809 768 <2587> Suntory BF 49374521 <2749> JPHD 605515 <2897> Nissin Food HD 31002911 <2982> AD Works Group 229219 <3093> Trade Factory 15201455 <3221> Yoshix 28512759 <3
Petroleum resources, light industry, etc. (additional) Rating
Upgraded - Bullish Code Stock Name Brokerage Firm Previous Changed After-------------------------------------------------------------<268A> Rigaku Nomura "Hold" "Buy" <3626> TIS GS "Hold" "Buy" <4528> Ono Pharmaceutical City "3" "2" <6752> Panasonic HD Morgan Stanley "Equal Weight" "Over Weight" <7735> Screen Morgan Stanley "Equal Weight" "Over Weight"